Bavarian Nordic A/S (BAVA)

Bavarian Nordic is a Danish biotechnology company specializing in vaccines and immunotherapies, notably smallpox and mpox vaccines based on its MVA-BN platform (marketed in various regions as products such as Jynneos or Imvanex). It also works on other infectious-disease and cancer vaccine programs and supplies governments and public-health stockpiles as well as commercial markets. Manufacturing and long-term public contracts for preparedness vaccines are an important part of the model. The focus on poxvirus-vector vaccine technology sets it apart within specialty biopharma.

Market

Copenhagen

Sector

Healthcare

Trend

Uptrend

Last close

215.6 (-1.73% on the day)

MA50

189.92

MA200

189.93

52-week range

172.5–242.1

Market cap

16.1B DKK

P/E

11.01

Dividend yield

0%

Data as of

2026-09-04

All markets — KeepWinning global stock screener

Other companies on Copenhagen: Netcompany Group A/S (NETC), GN Store Nord A/S (GN), BioMar Group A/S (BIOMAR), Embla Medical hf. (EMBLA), UIE Plc (UIE), Jeudan A/S (JDAN)